Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)

CompletedOBSERVATIONAL
Enrollment

256

Participants

Timeline

Start Date

December 10, 2019

Primary Completion Date

May 20, 2024

Study Completion Date

May 20, 2024

Conditions
Multiple Sclerosis
Interventions
DRUG

Cladribine

No intervention will be administered as a part of this study. Participants who had switched from first-line DMD treatments to treatment with cladribine tablets in routine clinical practice will be assessed for 2 years in this study.

Trial Locations (61)

Unknown

KH der Barmherzige Brüder Eisenstadt - Neurology, Eisenstadt

Dr. Reinhard Krendl-Head, Sankt Veit an der Glan

Klinik Florisdorf, Vienna

University of Thrace, Medical School - Neurology Department, Alexandroupoli

251 General Air Force Hospital, Athens

417 NIMITS Hospital, Athens

Aeginiteion Hospital, University of Athens - A' Neurology Department, Athens

Attikon University Hospital, Athens

Evangelismos Hospital - Neurology Department, Athens

"Genaral Hospital of Elefsina Thriasio", Athens

"General Hospital of Athens Evangelismos", Athens

University of Ioannina - Neurology Department, Ioannina, Ioannina

University General Hospital of Larissa - Rheumatology Clinic, Larissa

Iatriko Palaioy Faliroy, Medical Center - Neurology Department, Palaió Fáliro

"General Hospital of Patra Agios Andreas", Pátrai

University General Hospital of Patra, Pátrai

AHEPA General Hospital of Thessaloniki, Thessaloniki

"General Hospital of Thessaloniki G. Papanikolaou", Thessaloniki

Interbalkan Hospital of Thessaloniki, Thessaloniki

Papageorgiou General Hospital Thessaloniki, Thessaloniki

St Luke's Hospital, Thessaloniki

Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII (Presidio Papa Giovanni XXIII) - Dipartimento di Neurologia, Bergamo

Fondazione Istituto G.Giglio di Cefalù - Neurologia-Centro Sclerosi Multipla, Cefalù

Università degli Studi G. D'Annunzio, Chieti

Azienda Ospedaliera Universitaria Arcispedale Sant'Anna - Neurologia, Cona

Ospedali Riuniti di Foggia - Neurology, Foggia

Azienda Socio Sanitaria Territoriale della Valle Olona (presidio di Gallarate) - Neurologia 2 - Sclerosi Multipla, Gallarate

Ospedale San Luca - S.C.Oncologia, Lucca

ASL 1 Avezzano L'Aquila Sulmona- Ospedale Regionale San Salvatore - Dipartimento di Neurologia, L’Aquila

IRCCS Centro Neurolesi Bonino Pulejo - U.O. di Neurofisipatologia ed Ambulatori, Messina

Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli - U.O.S. Malattie Degenerative del S.N.C., Napoli

Ospedale Maggiore della carità - Novara, Novara

Centro di Riferimento Regionale per la Sclerosi Multipla (CRESM) - SCDO Neurologia, Orbassano

Azienda Ospedaliero Universitaria Policlinico Paolo Giaccone - Dipartimento di Neuroscienze, Palermo

Azienda Ospedaliera di Udine Ospedale S. Maria della Misericordia - UO Neurologia, Perugia

"Grande Ospedale Metropolitano Bianchi Melacrino Morelli - Centro Regionale Epilessia", Reggio Calabria

Azienda Ospedaliera San Filippo Neri - Neurologia, Roma

Azienda Ospedaliera Universitaria Policlinico Umberto I - Università di Roma La Sapienza - Dip. di Neurologia e Psichiatria (servizio EMG), Roma

A. O. U. San Giovanni Di Dio e Ruggi D'Aragona - Struttura Complessa di Oculistica, Salerno

Azienda Ospedaliera Universitaria Integrata Verona (Ospedale Borgo Roma) - D.U.Neurologia, Verona

Vestre Viken HF Drammen Sykehus - former Sykehuset Buskerud, Drammen

Sykehuset Namsos, Namsos

Oslo Universitetssykehus HF - Ullevål, Oslo

Uniwersytecki Szpital Kliniczny w Bialymstoku - Dept of Neurology, Bialystok

Szpital Specjalistyczny im. L.Rydygiera w Krakowie - Neurology Department, Krakow

Szpital Uniwersytecki w Krakowie - Uniwersytet Jagiellonski Collegium Medicum, Krakow

Szpital Kliniczny im.Heliodora Swiecickiego Uniwersytetu Medycznego im.K. Marcinkowskiego w Poznaniu - Dept of Neurology, Poznan

Pomorski Uniwersytet Medyczny - Klinika Neurologii, Szczecin

Wojskowy Instytut Medyczny - Klinika Neurologiczna, Warsaw

SPZOZ Wojewodzki Szpital Specjalistyczny nr 3 w Rybniku, Żory

Centro Hospitalar de Lisboa Ocidental, E.P.E. - Hospital de Egas Moniz - Serviço de Neurologia, Lisbon

Unidade Local de Saúde de Matosinhos, EPE (Hospital Pedro Hispano) - Serviço de Neurologia, Matosinhos Municipality

Centro Hospitalar de São João, E.P.E. - Serviço de Neurologia, Porto

Hospital Garcia de Orta, EPE - Serviço de Neurologia, Pragal

Centro Hospitalar de Setubal, EPE - Hospital São Bernardo, Setúbal

Unidade Local de Saúde do Alto Minho, EPE - Serviço de Neurologia, Viana de Castelo

Inselspital - Universitaetsspital Bern - Neuropsychologische Rehabilitation, Neurologie, Bern

(CHUV), Centre Hospitalier Universitaire Vaudois - Departement des Neurosciences Cliniques, Lausanne

Luzerner Kantonsspital - Zentrum fuer Neurologie und Neurorehabilitation, Lucerne

Ospedale Regionale di Lugano - Neurologia, Lugano

Hôpital Régional Sion-Hérens-Conthey - Neurologie, Sion

All Listed Sponsors
collaborator

Merck Hellas sa., Greece, an affiliate of Merck KGaA, Darmstadt, Germany

UNKNOWN

lead

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT04934800 - Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS) | Biotech Hunter | Biotech Hunter